European Archives - Page 265 of 1180 - European Medical Journal

How to maximise your year-end medical affairs and marketing budget

In the final quarter of the year, how can pharmaceutical teams make their final budget decisions count?

Behind the Breakthroughs: Tackling Vasculitis and Emerging Inflammatory Diseases

In this episode, Jonathan is joined by John H. Stone, Professor of Medicine at Harvard Medical School and The Edward A. Fox Chair in Medicine at Massachusetts General Hospital

Methods for Detecting Pancreatic Neoplasms

A novel deep-learning method utilising endoscopic ultrasound images could significantly enhance the detection of pancreatic neuroendocrine neoplasms according to recent research

Handshake on a green background

Merck acquires Modifi Biosciences in $1.3bn cancer therapy deal

The acquisition strengthens Merck’s oncology portfolio as the company looks to off the expiration of the patent for pembrolizumab.

Can Helicobacter Pylori Screening Prevent Gastric Cancer?

A trial investigated the effects of adding Helicobacter pylori stool antigen testing to colon cancer screening on rates of gastric cancer incidence and mortality.

Epigenetic Test May Predict Immunotherapy Success in Multiple Myeloma

Researchers have made a significant discovery that could one day help tailor immunotherapy treatments for patients with multiple myeloma.

Researchers Reveal the Symptoms of Long COVID are Caused by Brainstem Damage

New research using advanced 7T MRI has uncovered microscopic abnormalities in the brainstem of long COVID patients, revealing inflammation up to 18 months post-infection

Advances in proteinuria-targeting therapy in IgAN

Advances in Therapy to Address Proteinuria in Patients with Immunoglobulin A Nephropathy. As the majority of patients with IgA…

Carlos Caldas

Onc Now: Episode 3: Redefining Breast Cancer

This week, Jonathan Sackier is joined by Carlos Caldas, a world-leading expert in breast cancer research and clinician scientist at the University of Cambridge.

Genetic Risk of Hidradenitis Suppurativa Linked to Cardiometabolic Disease

A cohort study has examined whether an increased genetic risk of hidradenitis suppurativa is linked to a higher likelihood of developing cardiometabolic diseases.